Akanda Corp. (AKAN)
USD 1.16
(5.45%)
USD 1.16
(5.45%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -32.27 Million USD | -8228.82% |
| 2022 | 397.04 Thousand USD | 104.3% |
| 2021 | -9.22 Million USD | -213.11% |
| 2020 | -2.94 Million USD | -56.0% |
| 2019 | -1.88 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -2.68 Million USD | 0.0% |
| 2023 Q2 | -5.87 Million USD | -100.0% |
| 2023 Q3 | -13.19 Million USD | -124.55% |
| 2023 FY | -32.27 Million USD | -8228.82% |
| 2023 Q1 | -2.93 Million USD | 67.58% |
| 2023 Q4 | -13.19 Million USD | 0.0% |
| 2022 Q1 | 576.64 Thousand USD | 120.51% |
| 2022 FY | 397.04 Thousand USD | 104.3% |
| 2022 Q3 | -4.69 Million USD | -80.99% |
| 2022 Q4 | -9.06 Million USD | -93.08% |
| 2022 Q2 | -2.59 Million USD | -549.8% |
| 2021 Q3 | -4.74 Million USD | -6375.29% |
| 2021 FY | -9.22 Million USD | -213.11% |
| 2021 Q4 | -2.81 Million USD | 40.7% |
| 2021 Q2 | -73.2 Thousand USD | 0.0% |
| 2021 Q1 | -73.2 Thousand USD | -112.51% |
| 2020 Q4 | 585.41 Thousand USD | 0.0% |
| 2020 FY | -2.94 Million USD | -56.0% |
| 2019 FY | -1.88 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 48.15 Million USD | 167.023% |
| Embecta Corp. | 70.4 Million USD | 145.845% |
| ANI Pharmaceuticals, Inc. | 18.77 Million USD | 271.868% |
| Dynavax Technologies Corporation | -6.38 Million USD | -405.166% |
| Esperion Therapeutics, Inc. | -209.24 Million USD | 84.576% |
| Pacira BioSciences, Inc. | 41.95 Million USD | 176.928% |
| PainReform Ltd. | -9.34 Million USD | -245.41% |
| Aquestive Therapeutics, Inc. | -7.87 Million USD | -310.103% |
| Sunshine Biopharma, Inc. | -4.5 Million USD | -616.262% |
| SCYNEXIS, Inc. | 67.04 Million USD | 148.142% |
| China SXT Pharmaceuticals, Inc. | -3.09 Million USD | -941.625% |
| Cosmos Health Inc. | -18.54 Million USD | -74.059% |
| Journey Medical Corporation | -3.85 Million USD | -737.661% |
| Sunshine Biopharma, Inc. | -4.5 Million USD | -616.262% |
| Safety Shot Inc | -15.08 Million USD | -113.983% |
| Alpha Teknova, Inc. | -36.78 Million USD | 12.248% |
| Intra-Cellular Therapies, Inc. | -139.67 Million USD | 76.893% |
| Bright Green Corporation | -13.12 Million USD | -145.856% |
| Procaps Group, S.A. | 42.54 Million USD | 175.87% |
| Theratechnologies Inc. | -23.95 Million USD | -34.721% |
| Harrow Health, Inc. | -24.41 Million USD | -32.215% |
| Sonoma Pharmaceuticals, Inc. | -4.83 Million USD | -567.53% |
| Biofrontera Inc. | -20.13 Million USD | -60.325% |
| DURECT Corporation | -27.62 Million USD | -16.837% |
| Supernus Pharmaceuticals, Inc. | 1.31 Million USD | 2552.513% |
| Cronos Group Inc. | -73.96 Million USD | 56.363% |
| OptiNose, Inc. | -35.48 Million USD | 9.041% |
| Ironwood Pharmaceuticals, Inc. | -1 Billion USD | 96.78% |
| Kala Pharmaceuticals, Inc. | -42.19 Million USD | 23.517% |
| RedHill Biopharma Ltd. | 23.91 Million USD | 234.952% |
| Organogenesis Holdings Inc. | 4.94 Million USD | 752.681% |
| Guardion Health Sciences, Inc. | 158.03 Thousand USD | 20522.994% |
| Cumberland Pharmaceuticals Inc. | -6.27 Million USD | -413.99% |
| Radius Health, Inc. | -25.79 Million USD | -25.141% |
| Universe Pharmaceuticals INC | -6.16 Million USD | -423.686% |
| ProPhase Labs, Inc. | -16.78 Million USD | -92.32% |
| Phibro Animal Health Corporation | 2.41 Million USD | 1435.889% |
| Procaps Group S.A. | 42.54 Million USD | 175.87% |
| Alvotech | -551.73 Million USD | 94.15% |
| TherapeuticsMD, Inc. | -10.27 Million USD | -214.021% |
| Viatris Inc. | 54.7 Million USD | 159.004% |
| Rockwell Medical, Inc. | -8.43 Million USD | -282.451% |
| Aytu BioPharma, Inc. | -15.84 Million USD | -103.705% |
| SIGA Technologies, Inc. | 68.06 Million USD | 147.415% |
| Tilray Brands, Inc. | -244.98 Million USD | 86.825% |
| Lifecore Biomedical, Inc. | 12.01 Million USD | 368.668% |
| Shineco, Inc. | -22.44 Million USD | -43.771% |
| PetIQ, Inc. | 2.13 Million USD | 1614.55% |
| Regencell Bioscience Holdings Limited | -4.3 Million USD | -650.263% |
| Incannex Healthcare Limited | -18.45 Million USD | -74.847% |
| Neurocrine Biosciences, Inc. | 249.7 Million USD | 112.926% |
| Alimera Sciences, Inc. | -20.13 Million USD | -60.317% |
| Silver Spike Investment Corp. | 7.34 Million USD | 539.708% |
| Assertio Holdings, Inc. | -331.94 Million USD | 90.277% |
| Shuttle Pharmaceuticals Holdings, Inc. | -6.59 Million USD | -389.556% |
| Petros Pharmaceuticals, Inc. | -8.16 Million USD | -295.373% |
| Clever Leaves Holdings Inc. | -17.89 Million USD | -80.318% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | -60.914% |
| Avadel Pharmaceuticals plc | -160.27 Million USD | 79.863% |
| Hempacco Co., Inc. | -13.12 Million USD | -145.885% |
| Talphera, Inc. | -18.39 Million USD | -75.437% |
| Alvotech | -551.73 Million USD | 94.15% |
| Eagle Pharmaceuticals, Inc. | 35.64 Million USD | 190.553% |
| Lantheus Holdings, Inc. | 326.66 Million USD | 109.88% |
| Currenc Group, Inc. | -15.3 Million USD | -110.858% |
| Kamada Ltd. | 8.28 Million USD | 489.607% |
| Indivior PLC | 2 Million USD | 1713.754% |
| Evoke Pharma, Inc. | -7.79 Million USD | -314.192% |
| Flora Growth Corp. | -57.03 Million USD | 43.413% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | -60.914% |
| Evolus, Inc. | -61.68 Million USD | 47.678% |
| HUTCHMED (China) Limited | 100.78 Million USD | 132.025% |
| Amphastar Pharmaceuticals, Inc. | 137.54 Million USD | 123.465% |